Lithium and building products: This fund manager thinks these 2 ASX 200 shares are buys

Looking for outperformance? These two could keep delivering.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • Fund manager L1 is cautious about the flow-on effects of interest rate rises
  • It says shares in lithium miner Allkem could do well from a combination of cost synergies and valuation re-rating
  • Meantime, it notes building products manufacturer James Hardie just delivered impressive guidance

Fund manager L1 Capital has picked out two strong S&P/ASX 200 Index (ASX: XJO) share performers that it thinks can do well.

L1 has said it's cautious about the outlook for the stock market because of the looming impact of "significant interest rate hikes, weakness in leading economic indicators, gradually increasing pressure on corporate earnings and lingering tail risk from geopolitical tensions".

That said, the fund manager has identified "numerous mispriced stocks" that it believes will deliver "attractive long-term returns" for investors.

L1 Capital revealed two ASX 200 shares that it thinks will continue to do well.

A businessman in soft-focus holds two fingers in the air in the foreground of the shot as he stands smiling in the background against a clear sky.

Image source: Getty Images

Allkem Ltd (ASX: AKE)

Allkem is one of the largest lithium miners on the ASX. The Allkem share price jumped around 20% in May, as we can see on the chart below.

L1 explained the rise was due to the announcement of the all-stock "merger of equals" with Livent with the aim of creating a "leading, global, integrated lithium chemicals producer". The fund manager said the combined business is predicted to be the third-largest lithium producer in the world by 2027. It's expected to have a production capacity of around 250kt per annum of lithium carbonate equivalent.

One of the benefits of the merger is the expected cost synergies of around US$125 million per year and a one-time capital expenditure saving of around US$200 million.

L1 notes that Livent management will lead the combined entity, which will have a primary listing in the US. The fund manager believes the ASX 200 lithium share could attract a higher valuation multiple in line with US peers such as Albemarle.

James Hardie Industries plc (ASX: JHX)

The James Hardie share price was another leading performer in May after rising by 13%, as we can see on the chart below.

L1 noted the ASX 200 share rose after revealing FY24 first-quarter earnings guidance that was well above market expectations.

The fund manager noted there "continues to be uncertainty in terms of the impact that rising interest rates will have on housing, and on repair and remodel demand".

But L1 believes the company has provided confidence it can "maintain strong margins even allowing for a sharp decline in fibre cement volumes". It added:

This is driven by its more resilient end-market exposure, the benefits of its product mix shifting towards higher-margin products and its proactive cost management program. We continue to believe James Hardie is well placed to manage through the current period of softer demand and thereafter, to continue to grow at an above-market rate for many years to come.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ASX Share Market News

Broker written in white with a man drawing a yellow underline.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Five healthcare workers standing together and smiling.
ASX Share Market News

ASX 200 healthcare shares soar 9% amid notable FY26 reports from CSL, Pro Medicus

Healthcare outperformed while the ASX 200 weakened as earnings season continued last week.

Read more »

ETF in grey and exchange traded fund in blue.
Broker Notes

Expert names 2 top ASX ETFs to buy today

A leading analyst expects these two ASX ETFs are well-placed to outperform.

Read more »

A businessman lights up the fifth star in a lineup, indicating positive share price for a top performer
Broker Notes

Bell Potter names the best ASX shares to buy in August

These could be the best of the best according to the broker.

Read more »

A happy young woman in a red t-shirt hold up two delicious burritos.
Consumer Staples & Discretionary Shares

Why I'd still buy Guzman Y Gomez shares after its big rise

GYG has won back investors with tasty growth. I think it’s still a buy.

Read more »

Hand holding Australian dollar (AUD) bills, symbolising ex dividend day. Passive income.
ASX Share Market News

If I invest $15,000 in Telstra shares, how much passive income will I receive in 2027?

Telstra is a top blue-chip for passive income.

Read more »

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

It wasn't a great Friday session for the ASX.

Read more »

three excited doctors with hands in the air
Broker Notes

Buy, hold, sell: Super Retail, APA, Sonic Healthcare shares

As earnings season continues, brokers have issued new ratings on these 3 ASX 200 shares.

Read more »